A long-running study following thousands of older adults suggests that a relatively brief period of targeted brain training may have effects that last decades.
Starting in the late 1990s, close to 3,000 older adults enrolled in a research project designed to test whether structured brain training could improve memory and thinking skills. Two decades after the study began, many of those participants were still showing lasting benefits.
A recent follow-up from the Advanced Cognitive Training for Independent and Vital Elderly, or ACTIVE, study found that people who completed cognitive speed training, along with additional booster sessions one and three years later, had a significantly lower risk of developing dementia. Over a 20-year period, their likelihood of receiving a dementia diagnosis was reduced by 25 percent.
According to the research team, this is among the first findings from a large randomized, controlled trial to show that any type of intervention, including cognitive training, brain games, physical activity, dietary changes, or medication, can reduce the occurrence of Alzheimer's disease and related dementias. The results were published in the journal Alzheimer's & Dementia: Translational Research and Clinical Interventions.
Long-Term Benefits Beyond Expectations
Earlier analyses of the ACTIVE study had already shown that participants maintained cognitive gains five and 10 years after completing training. However, the persistence of these effects over such a long period surprised even the researchers involved.
Michael Marsiske, Ph.D., one of the study's six principal investigators and a professor and interim co-chair in the Department of Clinical and Health Psychology at the University of Florida College of Public Health and Health Professions, said the findings exceeded what the team originally expected.
"Participants who had the greatest advantage had a maximum of 18 training sessions over three years. It seemed implausible that we might still see benefits two decades later," Marsiske said. "Our initial findings had shown benefits of several training arms up to 10 years after training, with participants reporting fewer impairment in tasks of daily living and experiencing fewer motor vehicle crashes. Adding in these 20-year findings strongly suggests that engagement in cognitive training does no harm and may confer substantial benefit."
Why Speed Training Stood Out
Researchers believe the long-lasting impact of the speed-focused training may be linked to how the program adapts to each individual, adjusting difficulty as participants improve.
The ACTIVE study, supported by the National Institute on Aging and the National Institute of Nursing Research, was conducted across multiple sites and included 2,832 older adults. Participants were randomly assigned to one of three training groups focused on memory, reasoning, or speed of processing, with each group completing 10 sessions.
Training sessions typically lasted a little over an hour and were spread out over roughly six weeks. Some individuals were also randomly chosen to receive additional training sessions about one year and nearly three years after the initial program, while a control group did not receive any training at all.
After five years, participants in all trained groups retained benefits. Participants reported less difficulty performing tasks such as cooking, taking medication, and managing finances than their peers in the control group. Ten years on, researchers found that participants who received training in reasoning and speed of processing maintained cognitive improvements.
For the 20-year follow-up — those still living were now mostly in their 90s — the investigators reviewed participants' medical records to determine how many had been diagnosed with dementia. Those in the speed training group had cut their risk of dementia by one-quarter compared with participants in the control group.
How the Training Works
The speed training requires participants to process visual information on a computer screen and make quick decisions. As participants' speed and accuracy improved, the training got progressively more difficult. Speed training may cause physical changes to the brain, leading to new and stronger connections between brain networks. The speed training used in the study is now available through the company BrainHQ.
For those interested in incorporating cognitive training into their own health practice, it's never too late to begin, said Marsiske, who is also the leader of the Data Management and Statistics Core of the 1Florida Alzheimer's Disease Research Center.
"At enrollment, our participants ranged in age from 65 to 94 years," he said. "We found no substantial reduction of training benefit with age, suggesting that training can be started at any time."
The ACTIVE study has inspired the investigators to launch follow-up trials, develop new interventions, and explore how older adults may benefit from pairing cognitive training with other lifestyle habits such as physical exercise, nutrition, and hypertension management.
"We think this study encourages us, and the field, to continue incorporating cognitive training into multicomponent intervention programs for older adults," Marsiske said.
Reference: "Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study" by Norma B. Coe, Katherine E. M. Miller, Chuxuan Sun, Elizabeth Taggert, Alden L. Gross, Richard N. Jones, Cynthia Felix, Marilyn S. Albert, George W. Rebok, Michael Marsiske, Karlene K. Ball and Sherry L. Willis, 09 February 2026, Alzheimer's & Dementia: Translational Research & Clinical Interventions.
DOI: 10.1002/trc2.70197
News
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]















